Treatment Page 2 Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Quality of life in patients with advanced prostate cancer after apalutamide treatment

Posted by on Jan 12, 2020 in Prostate cancer | 0 comments

In a nutshell This study analyzed the health-related quality of life (HRQOL) in patients with metastatic castration-sensitive prostate cancer (MCSPC) after treatment with apalutamide (Erleada) and androgen deprivation therapy (ADT). The study found that apalutamide plus ADT was well tolerated and improved survival compared to ADT alone in these...

Read More

The role of androgen deprivation therapy plus radiotherapy in the treatment of prostate cancer after prostate surgery

Posted by on Jan 12, 2020 in Prostate cancer | 0 comments

In a nutshell This study compared the safety and effectiveness of short-term androgen deprivation therapy (ADT) combined with radiotherapy (RT) in patients who underwent radical prostatectomy (RP). The main finding was that the combination of ADT and RT reduced the risk of recurrence and disease progression in these patients. Some background RP is...

Read More

Evaluating high-dose cyclophosphamide for patients with hard-to-treat B-cell non-Hodgkin’s lymphoma

Posted by on Jan 12, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of high-dose cyclophosphamide (Cytoxan) for the treatment of relapsed or unresponsive non-Hodgkin’s lymphoma (NHL). This study concluded that high-dose cyclophosphamide was safe and effective for these patients. Some background Chemotherapy regimens remain a standard treatment...

Read More

How effective is long-term brentuximab vedotin treatment for patients with recurrent or non-responding Hodgkin’s lymphoma?

Posted by on Jan 12, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated long-term treatment with brentuximab vedotin (Adcetris) for patients with Hodgkin's lymphoma (HL) that has come back or stopped responding to treatment. This study concluded that this treatment had a long-term benefit for some patients. Some background Most patients with HL respond well to initial treatment....

Read More

Mirabegron improves the quality of life of older patients with overactive bladder

Posted by on Jan 10, 2020 in Overactive bladder | 0 comments

In a nutshell This study investigated the quality of life outcomes in patients with overactive bladder (OAB) of 65 years of age or more. Researchers suggested that patients with OAB who received mirabegron (Myrbetriq) had improved quality of life. Some background OAB consists of an uncontrolled need or urge to urinate. Some people will leak urine when...

Read More

Physiotherapy is an effective treatment option for freezing of gait in Parkinson’s disease

Posted by on Jan 9, 2020 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the short and long-term effects of physiotherapy in improving the freezing of gait in patients with Parkinson's disease. Researchers confirmed the effectiveness of physiotherapy in the treatment of these patients. Some background Parkinson's disease affects brain cells. These cells lose their...

Read More